1. Proarrhythmic effects of antiarrhythmic drugs

   Newsletter Article 08 February 2013 Pages: 2 - 2

2. Thyrotoxicosis therapy in nursing mothers

   Newsletter Article 08 February 2013 Pages: 2 - 3

3. Corticosteroids: withdrawal effects are avoidable …

   Newsletter Article 08 February 2013 Pages: 3 - 3

4. … and children should be monitored for growth disturbances during therapy

   Newsletter Article 08 February 2013 Pages: 3 - 3

5. Acebutolol

   Newsletter Article 08 February 2013 Pages: 4 - 4

6. Amiodarone

   Newsletter Article 08 February 2013 Pages: 4 - 4

7. Amphotericin B/flucytosine

   Newsletter Article 08 February 2013 Pages: 4 - 4

8. Anti-inflammatories non-steroidal

   Newsletter Article 08 February 2013 Pages: 5 - 5

9. Aspirin see Valproic acid interaction

   Newsletter Article 08 February 2013 Pages: 5 - 5

10. Atropine

    Newsletter Article 08 February 2013 Pages: 5 - 5

11. Azathioprine

    Newsletter Article 08 February 2013 Pages: 5 - 5

12. Benserazide see Levodopa/benserazide

    Newsletter Article 08 February 2013 Pages: 5 - 5

13. Beta-blockers

    Newsletter Article 08 February 2013 Pages: 5 - 6

14. Captopril

    Newsletter Article 08 February 2013 Pages: 6 - 6

15. Carbamazepine interaction

    Newsletter Article 08 February 2013 Pages: 6 - 6

16. Chlorphenamine

    Newsletter Article 08 February 2013 Pages: 6 - 7

17. Cimetidine

    Newsletter Article 08 February 2013 Pages: 7 - 7

18. Ciprofloxacin

    Newsletter Article 08 February 2013 Pages: 7 - 7

19. Clonidine

    Newsletter Article 08 February 2013 Pages: 7 - 7

20. Contraceptives, oral

    Newsletter Article 08 February 2013 Pages: 7 - 7

21. Desipramine

    Newsletter Article 08 February 2013 Pages: 7 - 8

22. Dichloralphenazone

    Newsletter Article 08 February 2013 Pages: 8 - 8

23. Diuretics see Carbamazepine interaction

    Newsletter Article 08 February 2013 Pages: 8 - 8

24. Estrogen

    Newsletter Article 08 February 2013 Pages: 8 - 8

25. Etidronic acid

    Newsletter Article 08 February 2013 Pages: 8 - 8

26. Etretinate

    Newsletter Article 08 February 2013 Pages: 8 - 8

27. Flucytosine see Amphotericin B/flucytosine

    Newsletter Article 08 February 2013 Pages: 8 - 8

28. Inferferon alpha 2

    Newsletter Article 08 February 2013 Pages: 9 - 9

29. Isotretinoin

    Newsletter Article 08 February 2013 Pages: 9 - 9

30. Ketoconazole

    Newsletter Article 08 February 2013 Pages: 9 - 9

31. Levodopa/benserazide

    Newsletter Article 08 February 2013 Pages: 9 - 10

32. Netilmicin

    Newsletter Article 08 February 2013 Pages: 10 - 10

33. Nifedipine

    Newsletter Article 08 February 2013 Pages: 10 - 10

34. Penicillamine

    Newsletter Article 08 February 2013 Pages: 10 - 10

35. Pentoxifylline

    Newsletter Article 08 February 2013 Pages: 10 - 11

36. Phenelzine

    Newsletter Article 08 February 2013 Pages: 11 - 11

37. Phenothiazines

    Newsletter Article 08 February 2013 Pages: 11 - 11

38. Phosphoric acid

    Newsletter Article 08 February 2013 Pages: 11 - 11

39. Proflavine

    Newsletter Article 08 February 2013 Pages: 11 - 12

40. Quinidine

    Newsletter Article 08 February 2013 Pages: 12 - 12

41. Quinine

    Newsletter Article 08 February 2013 Pages: 12 - 12

42. Rifampicin

    Newsletter Article 08 February 2013 Pages: 12 - 13

43. Suxamethonium

    Newsletter Article 08 February 2013 Pages: 13 - 13

44. Triamterene

    Newsletter Article 08 February 2013 Pages: 13 - 13

45. Vaccine, hepatitis B

    Newsletter Article 08 February 2013 Pages: 13 - 14

46. Vaccine, influenza virus

    Newsletter Article 08 February 2013 Pages: 14 - 14

47. Vaccine, tetanus

    Newsletter Article 08 February 2013 Pages: 14 - 14

48. Valproic acid interaction

    Newsletter Article 08 February 2013 Pages: 14 - 14

49. Warfarin

    Newsletter Article 08 February 2013 Pages: 14 - 15

50. Zidovudine

    Newsletter Article 08 February 2013 Pages: 15 - 15